Medicenna Therapeutics Corp. Increase Decrease Through Share-based Payment Transactions
Medicenna Therapeutics Corp. (MDNAF) reported Increase Decrease Through Share-based Payment Transactions of CAD 1.37 million for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes › Compensation Related Costs
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2023-06-27
| Period end | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|
| 2023-03-31 | 1.37M CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | 1.42M CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | 1.01M CAD 20-F · filed 2023-06-27 |
| 2020-03-31 | 1.13M CAD 20-F · filed 2022-06-22 |